Innovative Delivery Systems Enabling mRNA-Mediated Gene Editing in the Lung
- Explore how novel delivery platforms are overcoming biological and anatomical barriers to target lung tissue effectively through inhalation route
- Understand the potential of combining mRNA technology with next-generation carriers to achieve precise gene editing in pulmonary indications for diseases like PCD and cystic fibrosis
- Review emerging preclinical data showcasing safety, efficiency, and translational promise for respiratory gene editing therapies